FdaApplication
ANDA 206019
Identifiers
- fda_app_no: ANDA206019
Properties
| Property | Value |
|---|---|
| applicant_name | IPCA LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2025-07-15 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE | EQ 50MG BASE | TABLET;ORAL |
| SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE | EQ 100MG BASE | TABLET;ORAL |
| SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE | EQ 25MG BASE | TABLET;ORAL |
3 products